Literature DB >> 26078357

Accounting for dropout reason in longitudinal studies with nonignorable dropout.

Camille M Moore1, Samantha MaWhinney1, Jeri E Forster1,2, Nichole E Carlson1, Amanda Allshouse1, Xinshuo Wang1,3, Jean-Pierre Routy4, Brian Conway5, Elizabeth Connick6.   

Abstract

Dropout is a common problem in longitudinal cohort studies and clinical trials, often raising concerns of nonignorable dropout. Selection, frailty, and mixture models have been proposed to account for potentially nonignorable missingness by relating the longitudinal outcome to time of dropout. In addition, many longitudinal studies encounter multiple types of missing data or reasons for dropout, such as loss to follow-up, disease progression, treatment modifications and death. When clinically distinct dropout reasons are present, it may be preferable to control for both dropout reason and time to gain additional clinical insights. This may be especially interesting when the dropout reason and dropout times differ by the primary exposure variable. We extend a semi-parametric varying-coefficient method for nonignorable dropout to accommodate dropout reason. We apply our method to untreated HIV-infected subjects recruited to the Acute Infection and Early Disease Research Program HIV cohort and compare longitudinal CD4+ T cell count in injection drug users to nonusers with two dropout reasons: anti-retroviral treatment initiation and loss to follow-up.

Entities:  

Keywords:  B-spline; HIV/AIDS; dropout; longitudinal data; nonignorable missing data; varying-coefficient model

Mesh:

Year:  2015        PMID: 26078357      PMCID: PMC4679750          DOI: 10.1177/0962280215590432

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  34 in total

1.  Methods for the analysis of informatively censored longitudinal data.

Authors:  M D Schluchter
Journal:  Stat Med       Date:  1992 Oct-Nov       Impact factor: 2.373

2.  Selection models for repeated measurements with non-random dropout: an illustration of sensitivity.

Authors:  M G Kenward
Journal:  Stat Med       Date:  1998-12-15       Impact factor: 2.373

3.  Mixture models for the joint distribution of repeated measures and event times.

Authors:  J W Hogan; N M Laird
Journal:  Stat Med       Date:  1997 Jan 15-Feb 15       Impact factor: 2.373

Review 4.  Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis.

Authors:  Anupam Banerjee; Marianne Strazza; Brian Wigdahl; Vanessa Pirrone; Olimpia Meucci; Michael R Nonnemacher
Journal:  J Neurovirol       Date:  2011-07-07       Impact factor: 2.643

5.  Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection.

Authors:  G M Lucas; L W Cheever; R E Chaisson; R D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2001-07-01       Impact factor: 3.731

6.  A varying-coefficient method for analyzing longitudinal clinical trials data with nonignorable dropout.

Authors:  Jeri E Forster; Samantha MaWhinney; Erika L Ball; Diane Fairclough
Journal:  Contemp Clin Trials       Date:  2011-11-12       Impact factor: 2.226

7.  Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.

Authors:  D D Celentano; N Galai; A K Sethi; N G Shah; S A Strathdee; D Vlahov; J E Gallant
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

8.  Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study.

Authors:  P Pezzotti; N Galai; D Vlahov; G Rezza; C M Lyles; J Astemborski
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1999-03-01

9.  Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells.

Authors:  P K Peterson; G Gekker; S Hu; W R Anderson; F Kravitz; P S Portoghese; H H Balfour; C C Chao
Journal:  J Neuroimmunol       Date:  1994-03       Impact factor: 3.478

10.  Injecting drug use is associated with a more rapid CD4 cell decline among treatment naïve HIV-positive patients in Indonesia.

Authors:  Hinta Meijerink; Rudi Wisaksana; Shelly Iskandar; Martin den Heijer; Andre J A M van der Ven; Bachti Alisjahbana; Reinout van Crevel
Journal:  J Int AIDS Soc       Date:  2014-01-03       Impact factor: 5.396

View more
  4 in total

1.  The High-Intensity Exercise Study to Attenuate Limitations and Train Habits in Older Adults With HIV (HEALTH): A Research Protocol.

Authors:  Vitor H F Oliveira; Kristine M Erlandson; Paul F Cook; Catherine Jankowski; Samantha MaWhinney; Sahera Dirajlal-Fargo; Leslie Knaub; Chao-Pin Hsiao; Christine Horvat Davey; Allison R Webel
Journal:  J Assoc Nurses AIDS Care       Date:  2022 Mar-Apr 01       Impact factor: 1.354

2.  The role of individual differences in attentional blink phenomenon and real-time-strategy game proficiency.

Authors:  Natalia Jakubowska; Paweł Dobrowolski; Natalia Rutkowska; Maciej Skorko; Monika Myśliwiec; Jakub Michalak; Aneta Brzezicka
Journal:  Heliyon       Date:  2021-04-14

3.  Longitudinal change in physical functioning and dropout due to death among the oldest old: a comparison of three methods of analysis.

Authors:  Jani Raitanen; Sari Stenholm; Kristina Tiainen; Marja Jylhä; Jaakko Nevalainen
Journal:  Eur J Ageing       Date:  2019-09-18

Review 4.  A Bayesian natural cubic B-spline varying coefficient method for non-ignorable dropout.

Authors:  Camille M Moore; Samantha MaWhinney; Nichole E Carlson; Sarah Kreidler
Journal:  BMC Med Res Methodol       Date:  2020-10-07       Impact factor: 4.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.